Global Pharmaceutical Industry - Statistics & Facts
Statistics and facts about the pharmaceutical industry worldwide
The pharmaceutical industry is responsible for the development, production and marketing of medications. Thus, its immense importance as a global sector is evident. The total level of pharmaceutical revenue worldwide had reached nearly one trillion U.S. dollars. North America is responsible for the largest portion, generating more than 40 percent of these revenues. This is mostly due to the leading role of the U.S. pharmaceutical industry. But as in many other industries, the Chinese pharmaceutical sector shows the highest growth rates over the last years.
Still, the leading pharmaceutical companies come from the United States and Europe. Based on prescription sales, NYC-based Pfizer is the world’s second largest pharmaceutical company. In 2013, the company generated some 45 billion U.S. dollars in pure pharmaceutical sales, while total revenue stood at nearly 52 billion U.S. dollars. Other top global players from the United States are Johnson & Johnson, Merck and AbbVie. Novartis and Roche from Switzerland, GlaxoSmithKline and AstraZeneca from the United Kingdom, and French Sanofi are the European big five.
Branded, patented medicines by far make up the largest share of pharmaceutical revenues. Humira, an anti-inflammatory drug, generated nearly 10 billion U.S. dollars of revenue worldwide. Oncologics continue to be the leading therapeutic class based on revenue. In 2013, cancer drugs made around 67 billion U.S. dollars of revenue globally. Other major therapy classes were pain drugs, antihypertensives and antidiabetics.
More than any other industry, the pharmaceutical sector is highly dependent on its research and development segment. Pharmaceutical companies invest 20 percent and more of their revenues in R&D measures. The United States is a traditional stronghold of pharmaceutical innovation. Most new substances introduced to the market trace their origin to the United States. Because of the steadily loss of patent protection, the invention of new drugs is of vital importance for the pharmaceutical industry. Revenue losses due to patent expiry often are very significant, as it can be seen with Pfizer’s Lipitor.
Picture: freeimages.com / forwardcom
|Revenue of the worldwide pharmaceutical market||$1057.2bn||Details →|
|Revenue share of the North American pharmaceutical market||44.5%||Details →|
|Pharmaceutical sales in oncologics||$74.4bn||Details →|
|Companies and Products||Values||Statistic|
|℞ Sales of Pfizer||$47.4bn||Details →|
|Net income of Johnson & Johnson||$16.3bn||Details →|
|Sales of Humira||$11.84bn||Details →|
|Novartis AG total revenue||$49.4bn||Details →|
|Contribution to pharmaceutical market growth by China||40%||Details →|
|North American projected global pharmaceutical revenue in 2016||$371.8bn||Details →|
|Projected global spending on medicines by 2020||$1,415bn||Details →|
- Pharmaceutical market: worldwide revenue 2001-2014+Pharmaceutical market: worldwide revenue 2001-2014
Revenue of the worldwide pharmaceutical market from 2001 to 2014 (in billion U.S. dollars)
- Top 10 global pharmaceutical markets: growth 2010-2014+Top 10 global pharmaceutical markets: growth 2010-2014
Growth of top 10 national pharmaceutical markets worldwide from 2010 to 2014*
- Top 50 pharmaceutical companies - sales and R&D spending 2014+Top 50 pharmaceutical companies - sales and R&D spending 2014
Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2014 (in billion U.S. dollars)
- The complete topic in one convenient package
- Instant access and download
- Great time-saver
- Pharmaceuticals: cost of drug development in the U.S. since 1975Pharmaceuticals: cost of drug development in the U.S. since 1975
- U.S. Pharmaceuticals: spending on research and development 1980-2015U.S. Pharmaceuticals: spending on research and development 1980-2015
- Research and development expenditure: U.S. pharmaceutical industry 1995-2015Research and development expenditure: U.S. pharmaceutical industry 1995-2015
- U.S. pharmaceutical industry spending on research and development 1990-2015U.S. pharmaceutical industry spending on research and development 1990-2015
- U.S. pharmaceutical industry - domestic and abroad revenue 1975-2015U.S. pharmaceutical industry - domestic and abroad revenue 1975-2015